# The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction

> **NCT05045274** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 300 (estimated)

## Conditions studied

- STEMI - ST Elevation Myocardial Infarction
- Left Ventricular Systolic Dysfunction

## Interventions

- **DRUG:** Dapagliflozin 10Mg Tab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05045274
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12
- **Primary completion:** 2022-06
- **Final completion:** 2022-09
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05045274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05045274, "The Effect of Early Administration of Dapagliflozin in STEMI Patients With LV Systolic Dysfunction". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05045274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*